Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Federico Mingozzi, PhD
CHIEF SCIENTIFIC OFFICER, SPARK THERAPEUTICS
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
United States
Sandy Macrae, PhD
CEO, SANGAMO THERAPEUTICS
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
Marinna Madrid
CO-FOUNDER, CELLINO
Cellino
Cambridge, Massachusetts, United States
Carmen Maher
SENIOR DIRECTOR MEDICAL REGULATORY/SENIOR REGULATORY ADVISOR, JPEO CBRND AND DEFENSE THREAT REDUCTION AGENCY / JOINT SCIENCE AND TECHNOLOGY OFFICE (DTRA / JSTO)
Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics
Fort Detrick, Maryland, United States
Stanley Maloy, PhD
ASSOCIATE VICE PRESIDENT FOR INNOVATION, SAN DIEGO STATE UNIVERSITY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
Mathai Mammen, MD, PhD
GLOBAL HEAD, RESEARCH & DEVELOPMENT, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Doug Manion, MD
CEO, KLEO PHARMACEUTICALS, INC.
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
New Haven, Connecticut, United States
Husseini Manji, FRCP (C), MD
GLOBAL THERAPEUTIC AREA HEAD, NEUROSCIENCE, JOHNSON & JOHNSON
How COVID-19 Has Impacted the Global Psyche
Titusville, New Jersey, United States
Upendra Marathi
PRESIDENT & CEO, 7 HILLS PHARMA
7 Hills Pharma
Houston, Texas, United States
Heidi Marchand, PharmD, RPh
GLOBAL HEAD, REGULATORY POLICY AND INTELLIGENCE, GILEAD SCIENCES
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
United States
Magdalena Marciniak
BUSINESS ALLIANCE DIRECTOR, RYVU THERAPEUTICS
Ryvu Therapeutics
Gary Margolis
CEO, NOTOGEN, INC.
Notogen, Inc.
Toronto, Ontario, Canada
Jeff Margolis
CHAIRMAN, WELLTOK
Asymmetrical Challenges of Innovation
Brad Margus
CHIEF EXECUTIVE OFFICER, CEREVANCE
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
Boston, Massachusetts, United States
John Markels, PhD
PRESIDENT, MERCK VACCINES, MERCK & CO.
A Way Forward: Winning the War on COVID through Vaccines
North Wales, Pennsylvania, United States
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD & DRUG ADMINISTRATION
A Way Forward: Winning the War on COVID through Vaccines
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
FDA Town Hall
Silver Spring, Maryland, United States
Michael Markus, PhD
CEO, HGE HEALTH
Digital Health in Respiratory Care – The Next Frontier
Philadelphia, Pennsylvania, United States
Andy Marshall, PhD
CHIEF EDITOR, NATURE BIOTECHNOLOGY
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
United States
Brian Martin, BS, MS
HEAD OF AI IN R&D INFORMATION RESEARCH, SENIOR PRINCIPAL DATA SCIENTIST, ABBVIE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Lake Forest, Illinois, United States
Linda Masat
V.P. BUSINESS DEVELOPMENT, TRIANNI INC.
Trianni, Inc
San Francisco, CA, California, United States
Carmela Mascio
PRESIDENT & CO-FOUNDER, LIVONYX INC.
LivOnyx Inc.
Allston, Massachusetts, United States
Neal Masia, PhD
CEO, HEALTH CAPITAL GROUP
Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence
New York, New York, United States
Cristina Masseria, MSc, PhD
VP PATIENT HEALTH & IMPACT, VACCINES, PFIZER
Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence
Gary Mathias
CEO, THETIS PHARMACEUTICALS
Thetis Pharmaceuticals
Branford, Connecticut, United States
Kazuhiro Matsuda, MD, PhD
PRESIDENT, M BIO TECHNOLOGY INC.
M Bio Technology Inc.
Tokyo, Japan
Osamu Matsuzaki
BOARD DIRECTOR, SENIOR EXECUTIVE OFFICER, HEAD OF R&D AND BD, ASAHI KASEI PHARMA CORPORATION
Asahi Kasei Pharma Corporation
Tokyo, Japan
Martin Matthews
DIRECTOR OF GOVERNMENT AFFAIRS, MERCK & CO.
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
North Wales, Pennsylvania, United States
Allison Matusick
GLOBAL ACCOUNTS DIRECTOR, CORNING INCORPORATED
Corning Incorporated
Corning, New York, United States
Jeff May
VICE PRESIDENT, GLOBAL PUBLIC POLICY, MERCK
International Trade in the Times of COVID-19
Kenilworth, New Jersey, United States
Kiran Mazumdar Shaw
CHAIRPERSON & MANAGING DIRECTOR, BIOCON LIMITED
The Lure of Universal Healthcare ! What India is doing in Healthcare
Bangalore, India
James McArthur, BSc, D. Phil
FOUNDER & PRESIDENT, R&D, CYDAN
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Cambridge, Massachusetts, United States
Andrew McCandlish
HEAD OF US BUSINESS DEVELOPMENT, PH PHARMA
Getting a seat at the table: how can new small companies enter the oncology space?
South San Francisco, California, United States
Corey McCann, MD, PhD
FOUNDER & CEO, PEAR THERAPEUTICS
Asymmetrical Challenges of Innovation
Boston, Massachusetts, United States
Reenie McCarthy
CHIEF EXECUTIVE OFFICER, STEALTH BIOTHERAPEUTICS
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Newtown, Massachusetts, United States
Mark McClellan, MD
DIRECTOR, DUKE UNIVERSITY MARGOLIS CENTER FOR HEALTH POLICY
A Way Forward: Winning the War on COVID through Vaccines
Washington, United States
Barbara McClung
CHIEF LEGAL OFFICER AND CORPORATE SECRETARY, CARIBOU BIOSCIENCES, INC.
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
GETTING TO YES: Negotiating IP Terms in Contracts
Berkeley, California, United States
Joshua McClure, MBA
CEO, MAXWELL BIOSCIENCES
MaxWell Biosciences
Austin , Texas, United States
Mark McCord-Amasis, MBA, MSc
VICE PRESIDENT, REAL ESTATE & FACILITIES, SEATTLE GENETICS
Identify and Mitigate: “Bet Your Company” Risks
BOTHELL, Washington, United States
Andrew McKee, MD
CEO AND PRESIDENT, HEADLAND STRATEGY GROUP
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
Headland Strategy Group
San Francisco, California, United States
Matt McLoughlin
VP OF COMPLIANCE & CATEGORIES, SCIENTIST.COM
Scientist.com
Manchester, United Kingdom
Matthew McMahon
FEDERAL PROGRAM STAFF, NIH SEED
The Key Role of NIH in the Product Development Pipeline
United States
Gianna McMillan
PROGRAM ADMINISTRATOR, BIOETHICS INSTITUTE AT LOYOLA MARYMOUNT UNIVERSITY
Including the Patient Voice to Advance Diversity and Support Clear Communications
United States
Michelle McMurry-Heath, MD, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, BIOTECHNOLOGY INNOVATION ORGANIZATION
Biotech’s Finest Hour
Science on the Front Lines & on the Front Page
A Way Forward: Winning the War on COVID through Vaccines
Washington, United States
Jenn McNary
PATIENT ADVOCATE, J. MCNARY CONSULTING
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Boston, Massachusetts, United States
David Mead, PhD
CEO, VARIGEN BIOSCIENCES
Varigen Biosciences
Madison, Wisconsin, United States
Ravi Mehrota, PhD
, 5POINT0
Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future
Julien Meissonnier
VP & CSO, CATALENT
Technology Integrators in Cell and Gene Therapy: Powering Innovation
BioProcess Insider Interviews
Joseph (Joe) Melnik
PARTNER, JONES DAY
GETTING TO YES: Negotiating IP Terms in Contracts
Palo Alto, California, United States
Hanne Mette Kristensen
CEO, THE LIFE SCIENCE CLUSTER
The Nordics
Oslo, Norway
Philipp Mews, PhD
COFOUNDER , EPIVARIO INC.
PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care
New York, New York, United States
Annastasiah Mudiwa Mhaka, PhD
CO-FOUNDER, CONVENOR, FORMER PRESIDENT; FOUNDER, ALLIANCE FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE; MAWAMBO LIFESCIENCES
Can AI Prevent Epidemics?
Zhuqi Miao
INTERIM MANAGER, INSTITUTE OF PREDICTIVE MEDICINE , OKLAHOMA STATE UNIVERSITY—CENTER FOR HEALTH SYSTEMS INNOVATION (CHSI)
Oklahoma State University—Center for Health Systems Innovation (CHSI)
Stillwater, Oklahoma, United States
Michael Miller, PhD
CEO, PROTERIXBIO
Digital Health in Respiratory Care – The Next Frontier
Billerica, Massachusetts, United States
Debra Miller
CHIEF EXECUTIVE OFFICER & FOUNDER, CUREDUCHENNE
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Newport Beach, California, United States
Steve Miller, MD
EVP & CHIEF CLINICAL OFFICER, CIGNA CORPORATION
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Financing Transformative Therapies: Cross-sector perspective on value, payment and real-world evidence
Missouri, United States
Jennifer Miller, PhD
ASSISTANT PROFESSOR, FOUNDER, YALE SCHOOL OF MEDICINE, BIOETHICS INTERNATIONAL
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
Emily Milligan
EXECUTIVE DIRECTOR, BARTH SYNDROME FOUNDATION
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Elizabeth Mily
EXECUTIVE VICE PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT , BRISTOL MYERS SQUIBB
How to Get Acquired: What Companies Look for When in Acquisition Mode
Bristol Myers Squibb
Princeton , New Jersey, United States
Frank Minella
FOUNDER & CEO, PAINQX
PainQx
Philadelphia, Pennsylvania, United States
Brigitta Miranda-Freer
EXECUTIVE DIRECTOR, MONTANA WORLD TRADE CENTER
Montana - Global Innovation Hub
Missoula, Montana, United States
Tim Mitchell
CEO, SAREUM
Sareum Holdings plc
Cambridge, United Kingdom
Kenneth Moch
ADVISOR, COGNITION THERAPEUTICS AND CHIMERIX
Bioethics Through the Lens of a Pandemic
United States
James Moe
PRESIDENT AND CEO , OLIGOMERIX, INC.
Oligomerix, Inc.
Bronx, New York, United States
Amanda Moore
CEO , ANGELMAN SYNDROME FOUNDATION
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Indianapolis, Indiana, United States
K. Scott Moorefield
CHIEF BUSINESS OFFICER, BOUNDLESS BIO INC.
Boundless Bio Inc.
La Jolla , California, United States
Susan Moran, MD, MSc
CHIEF MEDICAL OFFICER, QED THERAPEUTICS / BRIDGEBIO
Looking for the Next Targeted Oncology Blockbuster
San Francisco, California, United States
Yusuke Moritoh
BIOLOGY TEAM1 HEAD, SCOHIA PHARMA, INC.
SCOHIA PHARMA, Inc.
Kanagawa, Japan
James Morrissey, PhD
PROFESSOR OF BIOLOGICAL CHEMISTRY & INTERNAL MEDICINE, UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
The human biologic response to vascular injury: a complex interaction among inflammation (innate and adaptive), coagulation and acuity of the injurious stimulus
Lonnie Moulder
FOUNDING PARTNER, TELLUS BIOVENTURES, LLC
How to Get Acquired: What Companies Look for When in Acquisition Mode
United States
Ryan Muldoon
CEO, PREP BIOPHARM
PrEP Biopharm
London, United Kingdom
Emily Mullin
STAFF WRITER, ONEZERO
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Rockville, Maryland, United States
Theresa Mulloy, BA
PROGRAM MANAGER INTERNATIONAL BUSINESS PROMOTION & INWARD INVESTMENT, PUGLIA SVILUPPO S.P.A.
Puglia Sviluppo S.p.A.
Modugno, Italy
Carolyn Mulroney
HEMATOLOGIST/MEDICAL ONCOLOGIST, ASSOCIATE PROFESSOR OF MEDICINE, UC SAN DIEGO HEALTH, UNIVERSITY OF CALIFORNIA SAN DIEGO
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
La Jolla, CA, California, United States
Ann Murray
DIRECTOR, BUSINESS DEVELOPMENT, CHARLES RIVER LABORATORIES
Charles River Laboratories
Wilmington , Massachusetts, United States
Anant Murthy, PhD
VICE PRESIDENT PRICING, MARKET ACCESS & POLICY, EUROPA/CANADA/MEA; GENERAL MANAGER, CANADA, BENELUX, NORDICS AND PORTUGAL, ALNYLAM PHARMACEUTICALS, INC.
Start Me Up: How Can Europe’s Biotech Sector Combat the Coronavirus?
Cambridge, Massachusetts, United States
Shankar Musunuri
CHAIRMAN AND CEO, OCUGEN
Ocugen, Inc.
Pennsylvania, United States
Nikolai Muth
PROJECT COORDINATOR, CITY OF YOKOHAMA REP. TO THE AMERICAS
City of Yokohama Rep. to the Americas
New York, New York, United States
Load More